Home
Conditions
Purpura, Thrombocytopenic

Clinical trial condition

Purpura, Thrombocytopenic

Explore clinical trials studying Purpura, Thrombocytopenic. Study availability and eligibility vary by location and protocol.

339 public trials 90 recruiting studies

Refine in advanced search Browse all conditions

Purpura, Thrombocytopenic trial results

Recruiting

BCMA-CD19 CAR-T Therapy for Refractory Autoimmune Diseases

NCT06794008

Conditions: ANCA-associated Vasculitis, Acquired Thrombotic Thrombocytopenic Purpura, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, +62 more
Locations: Department of Rheumatology and Immunology, Peking University People's Hospital Beijing, Beijing Municipality, China

View Trial Details

Recruiting

Biological Bank for the Patients Followed in a Constitutive Reference Center for Autoimmune Cytopenia

NCT04005638

Conditions: Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Autoimmune, +21 more
Locations: CHU de Bordeaux - service de médecine interne Pessac, France

View Trial Details

Recruiting

An Open, Exploratory Clinical Study of CM336 in the Treatment of Immune Thrombocytopenia

NCT06799611

Conditions: Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +17 more
Locations: Chinese Academy of Medical Science and Blood Disease Hospital Tianjin, Tianjin Municipality, China

View Trial Details

Recruiting

Avatrombopag in the Treatment of Adult Immune Thrombocytopenia With Autoantibodies

NCT04993885

Conditions: Autoantibodies, Autoimmune Diseases, Blood Coagulation Disorders, +21 more
Locations: Institute of Hematology & Blood Diseases Hospital Tianjin, Tianjin Municipality, China

View Trial Details

Recruiting

A Prospective, One-arm and Open Clinical Study of Zanubrutinib in the Treatment of Immune Thrombocytopenia

NCT05214391

Conditions: Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +17 more
Locations: Chinese Academy of Medical Science and Blood Disease Hospital Tianjin, Tianjin Municipality, China

View Trial Details

Recruiting

A Prospective, One-arm and Open Clinical Study of Obinutuzumab in the Treatment of Pediatric Primary Immune Thrombocytopenia (ITP)

NCT06094881

Conditions: Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +17 more
Locations: Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College Tianjin, China

View Trial Details

Recruiting

Avatrombopag in the Treatment of Pediatric Immune Thrombocytopenia

NCT06281327

Conditions: Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +17 more
Locations: Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College Tianjin, China

View Trial Details

Recruiting

A Prospective, One-arm and Open Clinical Study of Obinutuzumab in the Treatment of Immune Thrombocytopenia

NCT05995054

Conditions: Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +17 more
Locations: Chinese Academy of Medical Science and Blood Disease Hospital Tianjin, China

View Trial Details

Recruiting

Role of Eltrombopag as First Line Therapy in Primary Immune Thrombocytopenia.

NCT06531018

Conditions: Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations: Dhaka Medical College Hospital Dhaka, Bangladesh

View Trial Details

Recruiting

Cognitive Dysfunction in Chronic and Persistent Immune Thrombocytopenia

NCT06817395

Conditions: Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +20 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

View Trial Details

Purpura, Thrombocytopenic

Purpura, Thrombocytopenic trial results

Related conditions